NKTR News
Nektar Therapeutics
$36.89
-$1.03(-2.72%)
30
Overall
40
Value
9
Tech
42
Quality
Market Cap
$1.26B
Volume
1.00M
52W Range
$33.40 - $109.00
Target Price
$132.73
NKTR news: the latest Nektar Therapeutics headlines, press releases and market updates, newest first.
Latest NKTR News
- Analysts Offer Insights on Healthcare Companies: Nektar Therapeutics (NKTR), Roche Holding AG (OtherRHHVF) and Henry Schein (HSIC)TipRanks Newsroom · Oct 12, 2026
- B. Riley Securities Keeps Their Buy Rating on Nektar Therapeutics (NKTR)TipRanks Auto-Generated Intelligence Newsdesk · Oct 2, 2026
- Analysts Offer Insights on Healthcare Companies: DocGo (DCGO), Nektar Therapeutics (NKTR) and Stryker (SYK)TipRanks Newsroom · Sep 30, 2026
- Canaccord Genuity Sticks to Their Buy Rating for Nektar Therapeutics (NKTR)TipRanks Auto-Generated Intelligence Newsdesk · Sep 28, 2026
- Nektar Wins $90 Million Verdict in Lilly DisputeTipRanks Auto-Generated Newsdesk · Sep 25, 2026
- Nektar’s Rezpeg Trial Completion Adds a New Catalyst in Alopecia AreataTipRanks Clinical-Trials-Auto-Generated Newsdesk · Sep 18, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NKTR | $36.89 | -2.7% | 1.00M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |